This inventor holds 1 USPTO granted patent. Top assignee: Mallinckrodt Pharmaceuticals Ireland Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Peter Fernandes and Pulmonary Arterial Compliance
Introduction
Peter Fernandes is an inventor associated with Randolph, New Jersey, whose patent work addresses pulmonary arterial compliance and inhaled nitric oxide treatment. His disclosed invention describes methods intended to reduce pulmonary resistance and pressure while increasing pulmonary arterial compliance.
Latest Patents
The available information identifies one patent associated with Fernandes: “Pulmonary Arterial Compliance with Inhaled Nitric Oxide (iNO) Treatment.” The patent describes providing inhaled nitric oxide to reduce pulmonary resistance and pulmonary pressure and to increase pulmonary arterial compliance. The supplied information does not establish when the patent was granted or whether it is his latest filing.
Career Highlights
Fernandes is associated with Mallinckrodt Pharmaceuticals Ireland Limited. His identified patent reflects work in the area of pulmonary treatment and the potential use of inhaled nitric oxide to affect pulmonary vascular function. The supplied information lists 1 patent.
Collaborations
Parag Shah is identified as Fernandes’s coworker. The available details do not specify Shah’s role in the patent or the nature of their collaboration.
Conclusion
Peter Fernandes’s identified patent focuses on using inhaled nitric oxide to address pulmonary resistance, pressure, and arterial compliance, connecting his inventor profile with pulmonary treatment research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile